ADF GROUP INC (DRX.CA) Fundamental Analysis & Valuation

TSX:DRX • CA00089N1033

Current stock price

9.66 CAD
+0.19 (+2.01%)
Last:

This DRX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. DRX.CA Profitability Analysis

1.1 Basic Checks

  • DRX had positive earnings in the past year.
  • DRX had a positive operating cash flow in the past year.
  • Each year in the past 5 years DRX has been profitable.
  • DRX had a positive operating cash flow in 4 of the past 5 years.
DRX.CA Yearly Net Income VS EBIT VS OCF VS FCFDRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.14%, DRX belongs to the top of the industry, outperforming 91.53% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 16.03%, DRX belongs to the top of the industry, outperforming 93.40% of the companies in the same industry.
  • DRX has a better Return On Invested Capital (14.59%) than 95.77% of its industry peers.
  • DRX had an Average Return On Invested Capital over the past 3 years of 18.23%. This is above the industry average of 13.35%.
Industry RankSector Rank
ROA 9.14%
ROE 16.03%
ROIC 14.59%
ROA(3y)11.8%
ROA(5y)8.76%
ROE(3y)22.9%
ROE(5y)16.89%
ROIC(3y)18.23%
ROIC(5y)13.62%
DRX.CA Yearly ROA, ROE, ROICDRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • The Profit Margin of DRX (11.29%) is better than 91.41% of its industry peers.
  • DRX's Profit Margin has improved in the last couple of years.
  • The Operating Margin of DRX (17.56%) is better than 91.03% of its industry peers.
  • DRX's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 25.97%, DRX belongs to the best of the industry, outperforming 89.17% of the companies in the same industry.
  • DRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.56%
PM (TTM) 11.29%
GM 25.97%
OM growth 3Y76.93%
OM growth 5Y146%
PM growth 3Y69.95%
PM growth 5YN/A
GM growth 3Y53.12%
GM growth 5Y28.02%
DRX.CA Yearly Profit, Operating, Gross MarginsDRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

6

2. DRX.CA Health Analysis

2.1 Basic Checks

  • DRX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • DRX has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DRX has been reduced compared to 5 years ago.
  • Compared to 1 year ago, DRX has an improved debt to assets ratio.
DRX.CA Yearly Shares OutstandingDRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DRX.CA Yearly Total Debt VS Total AssetsDRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • DRX has an Altman-Z score of 2.80. This is not the best score and indicates that DRX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • DRX's Altman-Z score of 2.80 is in line compared to the rest of the industry. DRX outperforms 47.70% of its industry peers.
  • DRX has a debt to FCF ratio of 8.57. This is a slightly negative value and a sign of low solvency as DRX would need 8.57 years to pay back of all of its debts.
  • DRX has a better Debt to FCF ratio (8.57) than 89.66% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that DRX is not too dependend on debt financing.
  • The Debt to Equity ratio of DRX (0.21) is worse than 68.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 8.57
Altman-Z 2.8
ROIC/WACC1.23
WACC11.88%
DRX.CA Yearly LT Debt VS Equity VS FCFDRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • DRX has a Current Ratio of 2.27. This indicates that DRX is financially healthy and has no problem in meeting its short term obligations.
  • DRX has a Current ratio (2.27) which is comparable to the rest of the industry.
  • DRX has a Quick Ratio of 2.03. This indicates that DRX is financially healthy and has no problem in meeting its short term obligations.
  • DRX has a Quick ratio (2.03) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.03
DRX.CA Yearly Current Assets VS Current LiabilitesDRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

6

3. DRX.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 59.70% over the past year.
  • The Earnings Per Share has been growing by 84.52% on average over the past years. This is a very strong growth
  • DRX shows a small growth in Revenue. In the last year, the Revenue has grown by 2.60%.
  • DRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.58% yearly.
EPS 1Y (TTM)59.7%
EPS 3Y84.52%
EPS 5YN/A
EPS Q2Q%-29.03%
Revenue 1Y (TTM)2.6%
Revenue growth 3Y6.55%
Revenue growth 5Y13.58%
Sales Q2Q%1.8%

3.2 Future

  • Based on estimates for the next years, DRX will show a small growth in Earnings Per Share. The EPS will grow by 0.23% on average per year.
  • The Revenue is expected to grow by 8.59% on average over the next years. This is quite good.
EPS Next Y-40.72%
EPS Next 2Y0.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-24.78%
Revenue Next 2Y5.67%
Revenue Next 3Y8.59%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRX.CA Yearly Revenue VS EstimatesDRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DRX.CA Yearly EPS VS EstimatesDRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2024 2025 2026 2027 0 0.5 1 1.5 2

8

4. DRX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • DRX is valuated cheaply with a Price/Earnings ratio of 5.25.
  • Based on the Price/Earnings ratio, DRX is valued cheaply inside the industry as 97.63% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of DRX to the average of the S&P500 Index (27.42), we can say DRX is valued rather cheaply.
  • DRX is valuated cheaply with a Price/Forward Earnings ratio of 5.23.
  • DRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. DRX is cheaper than 97.38% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of DRX to the average of the S&P500 Index (22.29), we can say DRX is valued rather cheaply.
Industry RankSector Rank
PE 5.25
Fwd PE 5.23
DRX.CA Price Earnings VS Forward Price EarningsDRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DRX is valued cheaper than 98.75% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DRX is valued cheaper than 93.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.91
EV/EBITDA 3.27
DRX.CA Per share dataDRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • DRX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.23%
EPS Next 3YN/A

6

5. DRX.CA Dividend Analysis

5.1 Amount

  • DRX has a yearly dividend return of 0.42%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.85, DRX pays a better dividend. On top of this DRX pays more dividend than 95.27% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, DRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.42%

5.2 History

  • On average, the dividend of DRX grows each year by 8.48%, which is quite nice.
  • DRX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • DRX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.48%
Div Incr Years2
Div Non Decr Years14
DRX.CA Yearly Dividends per shareDRX.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0 0 0 0

5.3 Sustainability

  • DRX pays out 3.95% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DRX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP3.95%
EPS Next 2Y0.23%
EPS Next 3YN/A
DRX.CA Yearly Income VS Free CF VS DividendDRX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
DRX.CA Dividend Payout.DRX.CA Dividend Payout, showing the Payout Ratio.DRX.CA Dividend Payout.PayoutRetained Earnings

DRX.CA Fundamentals: All Metrics, Ratios and Statistics

ADF GROUP INC

TSX:DRX (4/24/2026, 7:00:00 PM)

9.66

+0.19 (+2.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-16
Earnings (Next)06-08
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap159.20M
Revenue(TTM)339.63M
Net Income(TTM)29.05M
Analysts84
Price Target13.26 (37.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.42%
Yearly Dividend0.03
Dividend Growth(5Y)8.48%
DP3.95%
Div Incr Years2
Div Non Decr Years14
Ex-Date04-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.92%
Min EPS beat(2)-85.86%
Max EPS beat(2)62.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.23%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)3.37%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.25
Fwd PE 5.23
P/S 0.62
P/FCF 31.91
P/OCF 10.5
P/B 0.88
P/tB 0.91
EV/EBITDA 3.27
EPS(TTM)1.84
EY19.05%
EPS(NY)1.85
Fwd EY19.13%
FCF(TTM)0.3
FCFY3.13%
OCF(TTM)0.92
OCFY9.52%
SpS15.62
BVpS10.99
TBVpS10.56
PEG (NY)N/A
PEG (5Y)N/A
Graham Number21.3349 (120.86%)
Profitability
Industry RankSector Rank
ROA 9.14%
ROE 16.03%
ROCE 19%
ROIC 14.59%
ROICexc 16.91%
ROICexgc 17.53%
OM 17.56%
PM (TTM) 11.29%
GM 25.97%
FCFM 1.94%
ROA(3y)11.8%
ROA(5y)8.76%
ROE(3y)22.9%
ROE(5y)16.89%
ROIC(3y)18.23%
ROIC(5y)13.62%
ROICexc(3y)24.54%
ROICexc(5y)17.69%
ROICexgc(3y)25.17%
ROICexgc(5y)18.15%
ROCE(3y)23.75%
ROCE(5y)17.74%
ROICexgc growth 3Y78.34%
ROICexgc growth 5Y166.39%
ROICexc growth 3Y78.21%
ROICexc growth 5Y166.39%
OM growth 3Y76.93%
OM growth 5Y146%
PM growth 3Y69.95%
PM growth 5YN/A
GM growth 3Y53.12%
GM growth 5Y28.02%
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 8.57
Debt/EBITDA 0.73
Cap/Depr 156.46%
Cap/Sales 3.95%
Interest Coverage 23.59
Cash Conversion 29.32%
Profit Quality 17.18%
Current Ratio 2.27
Quick Ratio 2.03
Altman-Z 2.8
F-Score5
WACC11.88%
ROIC/WACC1.23
Cap/Depr(3y)162.65%
Cap/Depr(5y)192.31%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.7%
EPS 3Y84.52%
EPS 5YN/A
EPS Q2Q%-29.03%
EPS Next Y-40.72%
EPS Next 2Y0.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.6%
Revenue growth 3Y6.55%
Revenue growth 5Y13.58%
Sales Q2Q%1.8%
Revenue Next Year-24.78%
Revenue Next 2Y5.67%
Revenue Next 3Y8.59%
Revenue Next 5YN/A
EBIT growth 1Y-44.56%
EBIT growth 3Y88.52%
EBIT growth 5Y179.4%
EBIT Next Year31.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-82.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.23%
OCF growth 3Y174.25%
OCF growth 5YN/A

ADF GROUP INC / DRX.CA Fundamental Analysis FAQ

What is the fundamental rating for DRX stock?

ChartMill assigns a fundamental rating of 7 / 10 to DRX.CA.


What is the valuation status of ADF GROUP INC (DRX.CA) stock?

ChartMill assigns a valuation rating of 8 / 10 to ADF GROUP INC (DRX.CA). This can be considered as Undervalued.


Can you provide the profitability details for ADF GROUP INC?

ADF GROUP INC (DRX.CA) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for DRX stock?

The Price/Earnings (PE) ratio for ADF GROUP INC (DRX.CA) is 5.25 and the Price/Book (PB) ratio is 0.88.


Can you provide the dividend sustainability for DRX stock?

The dividend rating of ADF GROUP INC (DRX.CA) is 6 / 10 and the dividend payout ratio is 3.95%.